image credit: Freepik

Biden administration aims to increase Medicaid drug transparency

May 24, 2023


The new proposal on drug transparency follows an October 2022 executive order President Joe Biden issued on lowering prescription drug costs, which directed the HHS to look into steps it could take to lower prescription drug costs for working and middle-class families.

It also comes on the heels of multiple House committee hearings where lawmakers on both sides of the aisle accused PBMs of profiting off the backs of patients and taxpayers.

The Biden administration is focused on increasing drug transparency for Medicaid, HHS Secretary Xavier Becerra said.

Read More on Healthcare Dive